Background Several clinical trials have reported inconsistent findings for the effect of fibrates on cardiovascular risk. We undertook a systematic review and meta-analysis to investigate …
Sodium (Na+) is the principal osmole in extracellular fluid; as such, the total body content of Na+ and Cl-, its primary anion, determine the extracellular fluid volume. Renal excretion or …
LR Brunham, JK Kruit, TD Pape, JM Timmins… - Nature medicine, 2007 - nature.com
Type 2 diabetes is characterized by both peripheral insulin resistance and reduced insulin secretion by β-cells. The reasons for β-cell dysfunction in this disease are incompletely …
When the'lipid nephrotoxicity hypothesis' was proposed in 1982, it brought together several disparate experimental findings in hyperlipidemia and renal disease to suggest that …
CK Abrass - American journal of nephrology, 2004 - karger.com
Dyslipidemia contributes to the rate of progression of atherosclerosis and chronic kidney disease. Also, chronic kidney disease leads to the development of secondary abnormalities …
SJCM Frambach, R de Haas, JAM Smeitink… - Pharmacological …, 2020 - Elsevier
Atherosclerosis is a leading cause of cardiovascular disease worldwide, and hypercholesterolemia is a major risk factor. Preventive treatments mainly focus on the …
A Tenenbaum, M Motro, EZ Fisman - Cardiovascular diabetology, 2005 - Springer
There are three peroxisome proliferator-activated receptors (PPARs) subtypes which are commonly designated PPAR alpha, PPAR gamma and PPAR beta/delta. PPAR alpha …
A Mitrofanova, G Burke, S Merscher… - World journal of …, 2021 - ncbi.nlm.nih.gov
Lipid dysmetabolism is one of the main features of diabetes mellitus and manifests by dyslipidemia as well as the ectopic accumulation of lipids in various tissues and organs …
BACKGROUND: Because of the major clinical and economic burden of diabetic nephropathy, new therapeutic tools to delay its progression are needed. Recent studies …